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AtherosclerosisThe Eph receptors represent the largest family of receptor tyrosine kinases. Both Eph receptors and their
ephrin ligands are cell-surface proteins, and they typically mediate cell-to-cell communication by interacting
at sites of intercellular contact.
The major aim of the present study was to investigate the involvement of EphA4–ephrin-A1 interaction in
monocyte adhesion to endothelial cells, as this process is a crucial step during the initiation and progression
of the atherosclerotic plaque.
Immunohistochemical analysis of human atherosclerotic plaques revealed expression of EphA4 receptor and
ephrin-A1 ligand in major cell types within the plaque. Short-time stimulation of endothelial cells with the
soluble ligand ephrin-A1 leads to a fourfold increase in adhesion of human monocytes to endothelial cells.
In addition, ephrin-A1 further increases monocyte adhesion to already inﬂamed endothelial cells. EphrinA1
mediates its effect on monocyte adhesion via the activated receptor EphA4. This ephrinA1/EphA4 induced
process involves the activation of the Rho signaling pathway and does not require active transcription. Rho
activation downstream of EphA4 leads to increased polymerization of actin ﬁlaments in endothelial cells.
This process was shown to be crucial for the proadhesive effect of ephrin-A1.
The results of the present study show that ephrin-A1-induced EphA4 forward signaling promotes monocyte
adhesion to endothelial cells via activation of RhoA and subsequent stress-ﬁber formation by a non-
transcriptional mechanism.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Atherosclerosis is still the leading cause of death in most developed
countries [1] and is therefore the target of broad scientiﬁc investiga-
tions. A crucial step in the development of an atherosclerotic lesion is
the adhesion of monocytes to endothelial cells [2]. Although the mech-
anismofmonocyte recruitment into the inﬂammatory vesselwall is not
fully understood, the process is thought to involve multiple steps.
The inﬂammatory character of atherosclerosis involves the activation
of endothelial cells that line the intima of the vessel wall. This inﬂam-
matory response leads to adhesion of monocytes and to an accumula-
tion of macrophages and other inﬂammatory cells in the intima [2,3].
Cardiovascular risk factors (as hypertension, dyslipidemia or
smoking) lead to increased presentation of various adhesion molecules
like vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesionicine and Cardiology, University
, Germany. Tel.: +49 351 450
sden.de (S. Jellinghaus).
of Cardiology, Angiology and
ny.
rights reserved.molecule 1 (ICAM-1) andmembers of the selectin family on the inner sur-
face of the vessel wall, which is known to be a crucial process for mono-
cyte adhesion to the vessel wall. Cell surface adhesion molecules like
ICAM-1 interact with intracellular cytoskeletal components [4–8]. The
functional signiﬁcance of these interactions is poorly understood. It has
been suggested that the anchorage of cell surface adhesion molecules
to intracellular cytoskeletal components contributes to ﬁrm adhesion.
The three small GTP-binding proteins Cdc42, Rac and RhoA regulate
actin cytoskeletal polymerization and remodeling, and cell–cell adhesion
[9–11]. In particular, RhoA is required for initiation and maintenance of
monocyte adhesion to endothelial cells via the clustering of monocyte
binding receptors without changing the expression level of the receptors
[12].
The Eph receptors represent the largest family of receptor tyrosine
kinases. Because both the Eph receptors and their ephrin ligands
are membrane-associated proteins, Eph–ephrin interactions typically
occur at sites of cell–cell contact. Remarkably, they generate bidirection-
al signals that affect both the receptor-expressing cells (forward signal-
ing) as well as the ligand-expressing cells (reverse signaling) [13]. Eph
receptors and ephrins are known to activate multiple signaling effec-
tors, including Src family kinases and Ras/Rho family GTPases [14–16].
The best known functions of Eph receptors and ephrins involve
regulation of developmental processes such as axonal guidance and
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proposed to play an important role in the communication between
endothelial cells and leukocytes in inﬂammatory diseases [19,20].
Interestingly, EphA2 receptor forward signaling inﬂuences the throm-
bin induced upregulation of the adhesion molecule ICAM-1 [21],
which may play an important role in the progression of atherosclero-
sis and potentially in plaque rupture.
Up to now, little is known about Eph/ephrin functions in the context
of the pathophysiology of atherosclerotic plaque development. In amu-
rine model it has been recently shown that ephrinB2 is overexpressed
at atherosclerosis predilection sites of the aorta and interacts with
EphB receptors in monocytes, which induces monocyte adhesion and
upregulates cytokine expression in monocytes [22]. In human athero-
sclerotic plaque ephrin-B1 and EphB2 are described to be expressed in
different cell types within the plaque [23] and several members of the
Eph family are expressed in atherosclerosis-related cells [24,25].
Recently it could be shown, that ephrinA1 induces the activation of
EphA2 in endothelial cells and generates proinﬂammatory gene expres-
sion suggesting a crucial role of Eph–ephrin signaling in atherosclerosis
[24].
Although the EphA4 receptor is known to be expressed in endothe-
lial cells little is known about the function of this receptor in the context
of inﬂammatory processes like atherosclerosis. Therefore, the present
study focuses on the analysis of the interaction of EphA4 receptor and
ephrin-A1 ligand in monocyte adhesion to human endothelial cells.
2. Methods
2.1. Cell isolation and culture
Primary humanmonocyteswere isolated frombuffy coats (Deutsches
Rotes Kreuz Dresden) by a two-step density gradient centrifugation and
cultured as described previously [26].
Human umbilical vein/artery endothelial cells (HUVECs/HUAECs)
were isolated from anonymously acquired umbilical cords. Human
aortic endothelial cells (HAECs) and human coronary aortic endothe-
lial cells (HCAECs) were purchased from Lonza. All endothelial cells
were cultivated as described previously [27].
THP-1 cells (human acute monocytic leukemia cell line, ATCC, USA)
were grown in RPMI 1640 medium (PAA, Austria) supplemented with
10% FCS and 1% antibiotics/antimycotics (PAA, Austria). The medium
was changed every 3 days. Subculturing of cells was done at a density
of 1 ∗ 106 cells/ml and the cells were resuspended at a density of
2 ∗ 105 cells/ml.
2.2. LDL preparation and oxidation
LDL was isolated from EDTA-anticoagulated plasma using a two-
step density gradient ultracentrifugation. After depletion of EDTA by
dialysis, the LDL-fraction was oxidized using 50 μM CuSO4 at 37 °C
for 24 h and was stopped by adding of 100 μM EDTA. Finally the
oxLDL was dialyzed against PBS.
2.3. siRNA transfection
Transient transfection of siRNA into HUVECs was done as
described previously [27]. The sequences of the used siRNAs are
summarized in Table 1. The siRNAs were purchased from MWG
Biotech.
2.4. Monocyte adhesion assay
HUVECs/HUAECs/HAECs/HCAECs were cultured at a density of
5.0 × 104 cells on a 24-well plate containing endothelial cell growth
medium (Promocell). After 24 h THP-1 cells or primary humanmonocytes were labeled for 60 min with Cell Tracker™ Red CMTPX
(5 μM in PBS, Invitrogen) at 37 °C and 5% CO2.
48 h after seeding the endothelial cells were pretreated for 30 min
with ephrin–A1–Fc (8 μg/ml, unclustered, R&D Systems), EphA4-Fc
(8 μg/ml, unclustered, R&D Systems) or with PBS and recombinant
human Fc (puriﬁed human IgG, MP Biomedicals, 4 μg/ml) as negative
controls. In inhibitor experiments, the inhibitor was added to the endo-
thelial cells before their stimulation. The blockers of the Rho signaling
pathway were added 30 min (Y27632, Sigma Aldrich) or 24 h
(c3-transferase, Cytoskeleton) before monocyte adhesion. The inhibi-
tors of actin-polymerization latrunculin B and cytochalasin D (both
Sigma-Aldrich) were applied to the endothelial cells 30 min before
ephrin-A1/Fc-stimulation. Tumor necrosis factor alpha (TNF-α,
10 ng/ml, R&D Systems) served as a positive control in all experiments
and was added to the endothelial cells 3 h before monocyte adhesion.
After stimulation, endothelial cells were washed twice to remove the
stimulants and monocytes (2 × 105) were seeded onto conﬂuent
pretreated endothelial cells and incubated for 1 h in serum-free RPMI
1640 to allow adhesion. Each condition was performed in duplicate.
After stringent washing of the cultured cells, the cells were ﬁxed
with 4% formalin for 20 min at room temperature and washed again
with PBS. The adhered red ﬂuorescent monocytes were quantiﬁed
using ﬂuorescence microscopy. For each condition 10 pictures with
100× magniﬁcation were taken in a deﬁned order. The counting of
the monocytes was done using Image J (NIH, USA).
2.5. Monocyte adhesion under ﬂow condition
For adhesion experiments of THP-1 cells under constant ﬂow con-
ditions the μ-SlideI-system (Ibidi) was used in combination with a
tubing pump (ECOLINE VC-MS/CA8-6, ISMATEC). In brief, HUVECs
were seeded conﬂuently on μ-Slide I0.6ibiTreat (2.5 ∗ 105 cells/slide)
and allowed to adhere overnight. A three-step ﬂow protocol was ap-
plied to the cells (1st: 30 min 2 dyn/cm2; 2nd: 30 min 5 dyn/cm2;
3rd: 48 h 10 dyn/cm2) for conditioning of the cells. After that, the
cells were stimulated for 30 min with Fc or ephrin-A1-Fc under static
condition. After this incubation the cells were washed three times
with PBS and reconnected to the ﬂow circle. The ﬂow medium was
then changed against RPMI without serum, which contains Cell-
Tracker™ Red-labeled THP-1 cells. The THP-1-cells were perfused
over the endothelial cells for 60 min. The interactions of THP-1 cells
and HUVECs were observed under the microscope and analyzed
with image and video acquisition.
2.6. Immunoprecipitation and Western blotting
Cells were cultured in culture dishes (∅ 10 cm). After stimulation,
cells were washed twice with ice-cold PBS and immediately
harvested using RIPA-buffer (50 mM Tris–Cl, pH 7.4; 150 mM NaCl;
0.25%(v/v) sodium–deoxycholate; 1% (v/v) NP-40; 1 mM EDTA;
1 mM Na3VO4) with protease inhibitors (Roche, Germany). Cell lysis
was done by shaking the suspension for 20 min on ice. Cell lysates
were obtained after centrifugation for 5 min at 14.000 ×g at 4 °C. Pro-
tein concentrations were determined by a modiﬁed Bradford method
(Nanoquant, Carl Roth). 100 μg total protein extract was incubated
with mouse anti-EphA4 (Invitrogen) overnight at 4 °C under rotation.
Antigen-antibody complexes were precipitated using Protein-G-
beads (Pierce Biotechnology). After 4 h incubation at 4 °C the bead
suspension was precipitated and washed with RIPA-buffer and
resuspended in Western Blot loading buffer (10% (v/v) glycerol;
50 mM Tris–Cl; 0.1 M DTT; 2% (w/v) SDS supplemented with
Bromophenol blue) and applied to standard western blot procedures.
For western blot the following antibodies were used: rabbit-anti-
EphA4 (Santa Cruz Biotechnology), rabbit-anti-ephrin-A1 (Santa
Cruz Biotechnology), rabbit-anti-VCAM-1 (Santa Cruz Biotechnolo-
gy), mouse-anti-ICAM-1 (Dako), mouse-anti-Phosphotyrosine (BD
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rabbit HRP (Santa Cruz Biotechnology).2.7. RhoA activation assay
RhoA activation assay was done using the RhoA Activation Assay
Kit (Cell Biolabs) according to the manufacturer's protocol. For immu-
noprecipitation 1 mg of protein extract was used. Equal loading was
proven by western blotting of 10 μg of each sample.Fig. 1. Expression and localization of EphA4 and ephrin-A1 in human atherosclerotic plaque
either stained for the expression of EphA4, the endothelial marker protein von Willebrand F
1A lower picture) or for EphA4, ephrin-A1 and the macrophage marker CD68 (1B lower
Aquaporin-1 positive capillary-like neovessels (1A upper picture) and expression of EphA4
cells (1B lower picture). Magniﬁcation (1A three pictures: 400×; 1A three small pictures: 12.8. Real-time RT-PCR
Total RNA was isolated using the NucleoSpin®II Kit (Macherey-
Nagel). cDNA was synthesized with the Revert Aid™ H Minus First
Strand Synthesis Kit (MBI Fermentas) from 1 to 5 μg total RNA with
Random Hexamer primers. cDNA from 30 ng total RNA was used for
each PCR reaction. Primers used are shown below. PCR was
performed with the iCycler real-time PCR System (BioRad, Hercules,
CA) using the SYBR®Premix ExTaq™ (Lonza, Basel, Switzerland).
The PCR conditions for all primer sets were as follows: initial. Serial sections of advanced human atherosclerotic plaques (from atherectomies) were
actor (vWF, 1A middle picture) and the neovessel-expressed Aquaporin-1 (Aquaporin,
picture). The EphA4 immunostaining shows receptor expression in areas of vWF and
(1B middle picture) and ephrinA1 (1B upper picture) in areas of CD68-positive foam
00× and 1B three big pictures: 630×, 1B three small pictures: 100×).
Table 1
Overview of the used siRNAs.
Target siRNA denotation siRNA sequence (5′ to 3′)
siScrambled Sense AGGUAGUGUAAUCGCCUUGTT
Antisense CAAGGCGAUUACACUACCUTT
EphA4 si628 Sense UCAGUCCGUGUGUUCUAUATT
Antisense UAUAGAACACACGGACUGATT
si2425 Sense GCAAUUGCCUAUCGUAAAUTT
Antisense AUUUACGAUAGGCAAUUGCTT
si2795 Sense AUUGGCUCCAGGCCAUUAATT
Antisense UUAAUGGCCUGGAGCCAAUTT
EphA2 si177 Sense UGACAUGCCGAUCUACAUGTT
Antisense CAUGUAGAUCGGCAUGUCATT
si2004 Sense GUUCAGCCACCACAACAUCTT
Antisense GAUGUUGUGGUGGCUGAACTT
si2181 Sense GUACCUGGCCAACAUGAACTT
Antisense GUUCAUGUUGGCCAGGUACTT
2204 S. Jellinghaus et al. / Biochimica et Biophysica Acta 1833 (2013) 2201–2211denaturation at 95 °C for 1 min followed by 45 ampliﬁcation cycles,
each consisting of 95 °C for 20 s, 58 °C for 45 s and 72 °C for 20 s
with a ﬁnal extension step at 72 °C for 2 min and a subsequent melt-
ing point analysis. Identity of PCR products was veriﬁed by agarose
gel electrophoresis, restriction enzyme digestion and sequencing of
the resulting PCR products. The primers were purchased from MWG
Biotech (Table 2).
2.9. Immunohistochemistry
The human atherosclerotic plaque specimenswere tissue samples of
advanced atherosclerotic carotid arteries. The anonymized plaque sam-
ples were kindly provided by Schmeisser and colleagues and the base-
line characteristics of the patients were already described [28].
Parafﬁn-embedded human atherosclerotic plaques (from atherectomy)
were serial sectioned and immunostained. After deparafﬁnization
the sections were incubated for 30 min in citrate buffer for antigen
retrieval, washed and incubated in the primary antibodies diluted in
Dako Antibody Dilutent (Dako): rabbit-anti-EphA4 (Santa Cruz);
rabbit-anti-ephrin-A1 (Zymed); mouse-anti-CD68 (Dako); rabbit-
anti-vWF (Dako); rabbit-anti-Aquaporin-1 (Chemicon). After washing
sections were incubated in secondary antibodies (anti-rabbit and
anti-mouse labeled polymer, Dako). For detection 3-amino-9-
ethylcarbazol (AEC, Dako) was used. The slides were counterstained
with hematoxylin–eosin for 1 min. Finally, the sections were mounted
on slides using Dako Ultramount (Dako).
Nonspeciﬁc immunoglobulins of comparable concentrations (“isotype
control”) or omission of the speciﬁc primary antibody (“blank control”)
was used as negative controls.
2.10. Phalloidin staining
HUVECs were ﬁxed in 4% formalin for 20 min at room tempera-
ture. Cells were blocked for 20 min using Dako protein block
(Dako). Phalloidin-tetramethylrhodamine B isothiocyanate (ﬁnal
concentration 7 μM) was diluted in Dako antibody dilutent with
background reduction (Dako) for 1 h. Nuclei were counter stained
with DAPI (0.1 μg/ml in PBS). Quantiﬁcation of the ﬂuorescence sig-
nal and the pseudo-color illustration was done using ImageJ (NIH).
2.11. Statistical analysis
Data are presented as mean ± standard deviation. Data were an-
alyzed using two-tail paired Student's t-test between two groups or
ANOVA with Student–Newman–Keuls post-hoc test. p-Values were
considered to be statistically signiﬁcant at different levels [(*)
p b 0.05, (**) p b 0.01 and (***) p b 0.001].
3. Results
3.1. Expression of the EphA4 receptor and the ephrin-A1 ligand in the
atherosclerotic plaque
Immunohistochemical staining for EphA4 receptor and ephrin-A1 li-
gand in advanced human atherosclerotic plaques showed a coexpressionFig. 2. Treatment of endothelial cells with ephrin-A1 enhances the adhesion of monocytes. H
with recombinant human Fc (4 μg/ml), ephrin-A1-Fc (8 μg/ml) and EphA4-Fc (8 μg/ml) for
incubated in serum-free culture medium for 1 h to allow adhesion. The ﬂuorescence imag
stimulation with TNF-α, ephrin-A1 or EphA4 (n = 7). The chart shows a quantiﬁcation of th
to HUVECs and HUAECs isolated from the same umbilical cord (n = 5) and HAECs, HCAEC
adhesion of primary human monocytes (purity ~85%), the adhesion assay was performed
of ephrin-A1 stimulation on monocyte adhesion to already inﬂamed HUVECs was studied
(n = 4) (D). To investigate the induction of monocyte adhesion under physiological ﬂow c
was applied for 48 h. After this initial conditioning, the cells were stimulated with equimola
tions. THP-1 cells (1 × 106 cells/ml) were incubated with the conditioned HUVECs for 60 m
after this incubation (E). The charts show means ± SD; *p b 0.05; **p b 0.01; ***p b 0.001of EphA4 and ephrin-A1 in areas where CD68 positive macrophages/
foam cells were found (Fig. 1B). The EphA4 receptor, which is known
to interact with ephrin-A1, was also expressed in areaswhere neovessels
were detected within the plaque as detected by vWF and aquaporin-1
staining of serially sectioned slides (Fig. 1A). The control stainings using
blank or isotype controls for the described antibodies showed negative
results. The results of the stainings of the different plaque specimens
are summarized within Table 3 to give a semiquantitative overview of
the expression in different cell types within the plaque.
3.2. Stimulation of endothelial cells with ephrin-A1 leads to enhanced
monocyte adhesion
To analyze a potential Eph receptor/ephrin-regulated interaction
of endothelial cells and monocytes/macrophages, we performed ad-
hesion assays using endothelial cells and the THP-1 monocyte cell
line or primary humanmonocytes. HUVECs were stimulated with sol-
uble ephrin-A1 or EphA4-Fc. We found that stimulation of HUVECs
with ephrin-A1-Fc for 30 min followed by removal of the ephrin
signiﬁcantly enhances subsequent adhesion of THP-1 cells (Fig. 2A,
Supplemental Fig. 1). In contrast, stimulation with EphA4-Fc does
not alter THP-1 cell adhesion compared to HUVECs treated with Fc
control. The extent of enhancement of THP-1 cell adhesion to HUVECs
induced by ephrin-A1 is comparable to that of TNF-α. Increased
monocyte adhesion to endothelial cells induced by TNF-α is known
to be important during the initiation of an atherosclerotic lesion
[29,30].
Ephrin-A1 stimulation of HUAECs also enhances the adhesion of
THP-1 cells as compared to HUVECs from the same umbilical vein.
In addition the ephrin-A1 mediated enhanced adhesion of monocytes
is also present in HAECs and HCAECs (Fig. 2B). These results suggest a
general effect of ephrin-A1 on different types of endothelial cells. Fur-
thermore, ephrin-A1 stimulation of HUVECs also promotes adhesion
of an enriched fraction of primary human monocytes (purity >85%
as indicated by CD14+ staining), which demonstrates that primary
human monocytes also display enhanced adhesion to ephrin-A1-
stimulated endothelial cells (Fig. 2C). Beyond that, the adhesion of
monocytes to already inﬂamed endothelial cells (3 h TNF-αUVECs were treated with either TNF-α (10 ng/ml) or PBS alone as a control for 3 h or
30 min. After this incubation and 2 washing steps, 2 × 105 THP-1 cells per well were
es show the adhesion of CellTracker™ Red-labeled THP-1 monocytes to HUVECs after
e results (A). The same setting was used to compare the adhesion of THP-1 monocytes
s (n = 4) (B). To investigate the inﬂuence of ephrin-A1 stimulation of HUVECs on the
using an enriched non-transformed human monocyte fraction (n = 7) (C). The effect
by stimulation of HUVECs with ephrin-A1 after a 3 h treatment with 10 ng/ml TNF-α
onditions, HUVECs were seeded in ﬂow chambers and continuous ﬂow (10 dyn/cm2)
r concentrations of Fc (4 μg/ml) or ephrin-A1 (8 μg/ml) for 30 min under static condi-
in under ﬂow conditions (10 dyn/cm2) and the adhered THP-1 cells were quantiﬁed
by Student's t-test.
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Table 2
Overview of the used primers for real-time RT-PCR.
Gene GenBank no. Primer name Sequence Fragment-size
ephrin-A1 NM_004428 EFNA1A-s TTG GGT CTG TGC TGC AGT C 123 bp
EFNA1A-as GAT GTC CAC GTA GTC ATT CAG C
EphA4 NM_004438 EPHA4-s TTT GTC ATC AGC CGG AGA CG 135 bp
EPHA4-as CTC TCG CAC TGC TTG GTT GG
HPRT1 NM_000194 HPRT1-h-s TTGCGACCTTGACCATCTTTG 96 bp
HPRT1-uni-as CTTTGCTGACCTGCTGGATTAC
ICAM-1 NM_000201 ICAM1-s GCG CCG GAA AGC TGT AGA TG 402 bp
ICAM1-as ACC ATG GAG CCA ATT TCT CG
VCAM-1 NM_001079 VCAM1-s GGA GGA TGC AGA CAG GAA GTC C 214 bp
VCAM1-as GCA GCT TTG TGG ATG GAT TCA C
2206 S. Jellinghaus et al. / Biochimica et Biophysica Acta 1833 (2013) 2201–2211treatment prior ephrin-A1 stimulation) is even further increased after
ephrinA1 stimulation (Fig. 2D). The proadhesive effect of ephrin-A1
was also observed under dynamic ﬂow conditions (Fig. 2E; video of
adhered monocytes after 1 h of ﬂow: Supplemental video).
3.3. Ephrin-A1 promotesmonocyte adhesion independently of transcription
Blockade of active transcriptionwith actinomycin D showed that the
ephrin-A1-induced increase in monocyte adhesion does not depend on
active transcription, suggesting a mechanism different from increased
transcription of adhesion molecules (Fig. 3A). This is in contrast to the
pro-adhesive effects of TNF-α on monocytes, which depend on tran-
scription (Fig. 3A), as previously reported [31,32]. Beside the depen-
dence on active transcription, we also exclude that mRNA stabilization
might be responsible for the observed enhanced adhesion. Therefore,Fig. 3. Ephrin-A1 enhances adhesion of monocytes to endothelial cells independently of tra
enhancement of monocyte adhesion, HUVECs were pretreated with 1 μg/ml actinomycin D p
of transcription has no inﬂuence on the ephrin-A1-mediated increase in monocyte adhesio
HUVECs were stimulated with TNF-α or ephrin-A1 (and PBS or Fc as controls) for 30 min
VCAM-1 (C) were measured by real-time RT-PCR. The protein expression of both monoc
30 min ephrin-A1 treatment that promotes monocyte adhesion did not alter the mRNA
*p b 0.05; **p b 0.01; ***p b 0.001 Student's t-test.the mRNA expression of the important monocyte binding receptors
ICAM-1 and VCAM-1 was determined by real-time PCR and showed
no alteration between ephrin-A1 treatment and the respective controls.
As expected TNF-α stimulation strongly induces the expression of
ICAM-1 and VCAM-1 (Fig. 3B and C). Furthermore modulation of their
protein expression by ephrin-A1 stimulation was also excluded as
shown in Fig. 3D.
3.4. Involvement of endothelial Rho signaling on ephrin-A1-dependent
monocyte adhesion
To gain insight into the mechanism of ephrin-A1-dependent in-
crease in monocyte adhesion, various signaling cascades were blocked
by chemical inhibitors. Treatment of HUVECs with the cell permeable
Rho inhibitor C3-transferase followed by stimulation with ephrin-A1-nscription. To get insight into the mechanism responsible for the ephrin-A1-mediated
rior to stimulation with TNF-α or ephrin-A1 to inhibit transcription (n = 3). Inhibition
n (A). To analyze the effect of ephrin-A1 stimulation on adhesion molecule expression,
(Fc, ephrinA1) or 180 min (PBS, TNF-α). The mRNA expression for ICAM-1 (B) and
yte binding receptors was analyzed by western blotting (D). The data show that the
and protein expression of these adhesion molecules. The charts show means ± SD
Table 3
The expressions of ephrinA1 and EphA4 were graded regarding the expression in
positive areas of the mentioned cell types over all positive plaque specimens.
Eph/ephrin Cell type Marker Expression/double
positive area
EphA4 Neovessels/endothelium Aquaporin, vWF ++
Macrophage/foam cell CD68 +++
T cells CD3 +
Smooth muscle cells α-Actin +++
ephrinA1 Macrophage/foam cell CD68 ++
Smooth muscle cells α-Actin +
Neovessels/endothelium Aquaporin, vWF +
Positive area: +… >0% and b25%; ++…25–50%; +++… >50%.
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HUVECs (Fig. 4A). To verify the involvement of the Rho signaling path-
way we also used Y27632, a chemical inhibitor of the ROCK kinase,
which is activated downstream of Rho [33,34]. Like C3-transferase,
Y27632 signiﬁcantly blocks the ephrin-A1-mediated enhancement of
THP-1 adhesion (Fig. 4B). Consistent with these results, stimulation of
HUVEC with ephrinA1 leads to an activation of RhoA signaling in endo-
thelial cells as shown in Fig. 4D.
As it is known that Rho activation promotes the formation of stress
ﬁbers, we stained ephrin-A1-stimulated HUVECs with phalloidin to
label ﬁlamentous actin. We indeed observed a signiﬁcant increase in
phalloidin labeling after stimulation with ephrin-A1 compared to the
Fc control (Fig. 4C), consistent with an increase in Rho activity.
3.5. EphA4 activation by ephrin-A1 in HUVECs is responsible for the
enhanced adhesion of monocytes
Stimulation of HUVECs with ephrin-A1 leads to increased EphA4
receptor tyrosine phosphorylation (Fig. 5A), which is indicative of
receptor activation [35]. To determine whether this activation of EphA4
is responsible for enhanced adhesion of THP-1 cells induced by
ephrin-A1 stimulation, a siRNA-mediated silencing approach was
used. Among three different siRNAs potentially targeting the EphA4
receptor that were tested, si2425 and si628 were shown to efﬁciently
downregulate EphA4 on mRNA and protein level (Fig. 5B and C).
EphA4 silencing abolishes the ephrin-A1-mediated stimulation ofmono-
cyte adhesion to HUVECs (Fig. 5D), HAEC and HCAEC (Supplementary
Fig. 3A and B), while a control scrambled siRNA does not. Furthermore,
an inﬂuence of the EphA2 receptor was excluded by siRNA-mediated si-
lencing of the EphA2 receptor (Supplemental Fig. 3A and B). EphA4 si-
lencing also inhibits the effects of ephrin-A1 stimulation on stress ﬁber
formation in HUVECs (Fig. 5E). To elucidate whether ephrin-A1 induces
adhesion of THP-1 cells to HUVECs through a mechanism that requires
ﬁlamentous actin, two inhibitors of actin polymerization, latrunculin B
and cytochalasinD,were applied toHUVECs prior ephrin-A1 stimulation.
As shown in Fig. 5F, both inhibitors signiﬁcantly inhibit the adhesion of
THP-1 monocytes to HUVECs after ephrin-A1 stimulation.
3.6. Ephrin-A1 expression is upregulated by oxLDL in macrophages
To investigate the inﬂuence of oxidized low density lipoprotein
(oxLDL) on the expression of the ephrin-A1 ligand, macrophages were
treated with oxidized LDL (100 μg/ml). Treatment of macrophages
with oxidized LDL for 12 h upregulates ephrin-A1 at themRNAand pro-
tein levels (Fig. 6A and B), in agreement with the expression of
ephrin-A1 in foam cells of the human atherosclerotic plaque detected
by immunohistochemistry (Fig. 1).
4. Discussion
The results of this study show that ephrin-A1-induced EphA4 for-
ward signaling in endothelial cells increases monocyte adhesion toendothelial cells already after 30 min. This fast monocyte adhesion
is independent of transcriptional activity and involves changes in
actin cytoskeleton formation. In comparison, it has recently been
shown that the ephrin-A1-dependent activation of the EphA2 recep-
tor in endothelial cells induces monocyte adhesion much later, after
5 h, by inﬂuencing the expression of VCAM-1 [24]. It could be exclud-
ed that the receptor EphA2 is involved in the ephrinA1 induced effect
described in this study (Supplemental Fig. 3).
In contrast to the induction of adhesion molecule expression after
long-term exposure to ephrin-A1 [24], the fast induction of monocyte
adhesion by ephrin-A1 described in the present study is not explain-
able by enhanced adhesion molecule expression. Instead of a
transcription-dependent increase in adhesion molecule expression,
which our experiments excluded (Fig. 3), we show that ephrin-A1 in-
duces cytoskeletal changes, which might change cell shape and the
presentation of cell surface molecules. Inhibition of actin polymeriza-
tion reduces the ephrin-A1-dependent increase in monocyte adhe-
sion. In agreement with this, we found an involvement of the RhoA
signaling pathway downstream of the EphA4 receptor, known to
modulate cytoskeleton changes. In synergy with these results it has
been shown that the clustering of adhesion receptors such as
E-selectin, VCAM-1 and ICAM-1 can occur through changes in their
association with the actin cytoskeleton, without changes in expres-
sion levels and that this process is exclusively regulated by RhoA
[12]. To inhibit actin polymerization and potential receptor clustering
we used cytochalasin D, which reduces the ephrin-A1 mediated in-
creased monocyte adhesion, conﬁrming our hypothesis that ephrin-
A1 induces monocyte adhesion to endothelial cells mainly by Rho-
mediated changes of the actin cytoskeleton. A second inhibitor of
actin-polymerization, latrunculin B was used to conﬁrm the hypothe-
sis of an involvement of the actin cytoskeleton in the proadhesive ef-
fect of ephrinA1. These data are in agreement with the effects
observed in neurons, where activation of the EphA4 receptor leads
to changes in the actin cytoskeleton mediated by activation of Rho
GTPases [36,37].
The speciﬁc silencing of EphA4 by two independent siRNA blocks
the ephrin-A1-induced effect on monocyte adhesion to endothelial
cells and reorganization of the actin cytoskeleton, demonstrating
the fundamental role of EphA4 in this process. The inhibition of the
receptor EphA2 showed no inﬂuence on the ephrinA1 induced effect
on monocyte adhesion described in this study (Supplemental Fig. 3).
Taken together, these results reveal that ephrinA1 induces two inde-
pendent proadhesive mechanisms. The ﬁrst mechanism is moderated
by an activation of the endothelial EphA4 receptor, which leads to
monocyte adhesion by cytoskeletal changes. The second mechanism is
mediated by an activation of the endothelial EphA2 receptor with sub-
sequent induction of VCAM-1, which leads to monocyte adhesion [24].
In contrast to the second mechanism, which was shown to work in
HAEC and not in HUVEC, the proadhesive effect of ephrin-A1 via
EphA4 was shown to be present in all tested endothelial cells. In addi-
tion, the short-time stimulation was also shown to further increase
the TNF-α induced monocyte adhesion. In concert, both mechanisms
demonstrate the complex proadhesive role of ephrinA1.
The immunohistochemical characterization of the expression pat-
terns of ephrin ligands and Eph receptors within atherosclerotic
plaques reveals the presence of EphA4 and ephrin-A1 in major cell
types within human atherosclerotic plaque. So far, mainly ephrin-B li-
gands, EphB receptors and the receptor EphA2 have been reported to
play a role in monocyte adhesion or in atherosclerotic plaque devel-
opment [19,22–24]. The expression of EphA4 in neovessels within
the plaque is not described in the literature so far. But it is known
that the EphA4 receptor is expressed in neovessels of different kinds
of tumors [38]. The result, that EphA4 can be found at sites of
neovessels leads to the assumption that EphA4 might be important
for the formation of neovessels during the atherosclerotic process.
But, further studies are needed to investigate this idea.
2208 S. Jellinghaus et al. / Biochimica et Biophysica Acta 1833 (2013) 2201–2211The ligand ephrinA1 is expressed in areas where CD68 positive cells
were found, and this expressionwas conﬁrmed by in vitro data showing
an upregulation of ephrin-A1 mRNA and protein upon oxidized LDLtreatment of primary human macrophages. The modiﬁed oxidized LDL
plays a key role in the pathogenesis of atherosclerotic plaque develop-
ment by inﬂuencing monocytes/macrophages, endothelial cells and
Fig. 5. Ephrin-A1 stimulation leads to activation of EphA4, which together with an intact actin cytoskeleton is crucial for enhanced monocyte adhesion. HUVECs were untreated
(control) or treated with Fc or ephrin-A1 for 30 min. EphA4 immunoprecipitates were probed for EphA4 and phosphotyrosine (n = 3). Stimulation with ephrinA1 leads to a phos-
phorylation of EphA4 (A). The silencing efﬁciency of three different siRNAs targeting the EphA4 receptor was analyzed on protein (B) and mRNA level (C) (n = 5). Effect of EphA4
silencing on the adhesion of THP-1 cells to stimulated HUVECs was analyzed. HUVECs were transfected with either scrambled siRNA (siScrambled) or siRNA targeting the EphA4
receptor (si2425, si628) and THP-1 adhesion was analyzed 48 h after transfection and following stimulation with Fc or ephrin-A1 for 30 min (n = 5) (D). To investigate the con-
sequences of EphA4 silencing for the formation of stress-ﬁbers, EphA4 silenced (si2425, si628) or siScrambled-transfected cells were treated with Fc or ephrin-A1 and stained with
phalloidin and DAPI to visualize the formation of stress ﬁbers (n = 3) (E). The silencing of endothelial EphA4 also inhibits the ephrinA1-mediated stress ﬁber formation. Inhibition
of actin polymerization was done using latrunculin B (1 μM) and cytochalasin D (10 nM) prior to Fc or ephrin-A1 stimulation and adhesion of THP-1 cells was analyzed (n = 4) (F).
These data demonstrate that the activation of EphA4 by ephrin-A1 is crucial for ephrin-A1-induced adhesion and formation of stress-ﬁbers. The charts showmeans ± SD *p b 0.05;
**p b 0.01 by Student's t-test.
2209S. Jellinghaus et al. / Biochimica et Biophysica Acta 1833 (2013) 2201–2211vascular smooth muscle cells (VSMCs). Besides oxidized LDL, another
pro-atherogenic stimulus, hypoxia, was shown to be able to induce
ephrin-A1 expression in endothelial cells. In murine endothelial cellsFig. 4. The Rho-signaling pathway is involved in ephrin-A1-induced monocyte adhesion to en
monocyte adhesion, HUVECswerepretreatedwith theC3 transferase exoenzyme 24 h before st
of Rho signaling blockage by inhibition of ROCKwas analyzed by pretreatmentwith 10 μMY276
Rho signaling reduces the ephrin-A1-induced adhesion of THP-1 to HUVECs. Because Rho signal
stimulation on the formation of stress ﬁbers. HUVECswere pretreatedwith Fc or ephrin-A1-Fc f
ﬁbers and with DAPI to visualize nuclei (n = 4) (C). The upper two pictures show the merged
twopictures show the phalloidin staining intensity (redﬂuorescence channel) in pseudo color im
staining, the mean ﬂuorescence intensity of the cell-covered area was calculated using ImageJ (
by immunoprecipitation and subsequent detection of GTP-bound RhoA. Equal loading was p
Rho-signaling is crucial for the ephrinA1-mediated monocyte adhesion. Beside the enhancem
show means ± SD *p b 0.05; **p b 0.01; ***p b 0.001 ANOVA with Student–Newman–Keuls pit was demonstrated that silencing of Hif-2α leads tomarkedly reduced
ephrin-A1 expression under hypoxic conditions [38]. In agreement
with these data we found that hypoxia is able to induce ephrin-A1dothelial cells. To analyze the impact of the Rho signaling pathway on ephrin-A1-induced
imulation of endothelial cellswith Fc or ephrin-A1-Fc (4 μg/ml) (n = 8) (A). The inﬂuence
32 for 1 h before stimulationwith ephrin-A1 or Fc respectively (n = 10) (B). Inhibition of
ing is known to be involved in stress-ﬁber formation, we analyzed the impact of ephrin-A1
or 30 min. Cells were then ﬁxed in formalin and stainedwith phalloidin to visualize stress
phalloidin and DAPI stainings for Fc- (left) and ephrin-A1-treated cells (right). The lower
age for Fc- (left) or ephrin-A1-stimulatedHUVECs (right). For quantiﬁcation of phalloidin
chart). RhoA activation in HUVECs upon ephrinA1 stimulation (15 min) was investigated
roven by western blotting of the protein extracts for RhoA (D). These data show, that
ent of adhesion ephrinA1 promotes stress ﬁber formation in endothelial cells. The charts
ost-hoc test (A, B) and Student's t-test (C).
Fig. 6. The proatherogenic factor oxidized LDL upregulates ephrin-A1 ligand expression.
Monocyte-derived macrophages were treated with 100 μg/ml oxidized LDL for 12 h
followed by analysis of ephrin-A1 mRNA expression by real-time RT-PCR (n = 5) and of
protein expression by Western blotting (n = 3). Oxidized LDL increased the expression
of ephrin-A1 at both the mRNA and protein level. The chart shows means ± SD
*p b 0.05 by Student's t-test.
2210 S. Jellinghaus et al. / Biochimica et Biophysica Acta 1833 (2013) 2201–2211expression in human endothelial cells (data not shown). These results
demonstrate that ephrin-A1 might be a regulatory target of inﬂamma-
tory stimuli in the atherosclerotic plaque. Based on the described
regulatory mechanism of ephrin-A1 in oxidized LDL-loaded foam cells,
ephrin-A1 in foam cells could interact with the EphA4 receptor in endo-
thelial cells in the atherosclerotic plaque, as it is known that foam cells
are located in direct vicinity of the endothelial layer in early stages of
atherosclerotic plaque [39]. This would lead to EphA4 activation and
enhanced adhesion of monocytes to the endothelium of the vessel
wall. Interactions of ephrin-A1 and coexpressed EphA4 receptor at
interendothelial cell contacts could also contribute to monocyte adhe-
sion to the endothelium.
5. Conclusion
The present study shows that ephrin-A1-induced EphA4 forward sig-
naling in endothelial cells increasesmonocyte adhesion to these cells. The
increased adhesion is dependent on the RhoA signaling pathway and
likely involves essential changes in the actin cytoskeletonwithout affect-
ing transcriptional activity. The expression of ephrin-A1 and EphA4 in
major cell types within atherosclerotic plaque suggests a potential func-
tion of EphA4 and ephrin-A1 interaction in plaque development.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.05.017.
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